Intraperitoneal implant of recombinant encapsulated cells overexpressing alpha-l-iduronidase partially corrects visceral pathology in mucopolysaccharidosis type I mice

References

• Matte U, Yogalingam G, Brooks D, Leistner S, Schwartz I, Lima L, . Identification and characterization of 13 new mutations in mucopolysaccharidosis type I patients. Mol Genet Metab. 2003;78:37–43.
   PubMed Web of Science ®Google Scholar
• Grigull L, Sykora KW, Tenger A, Bertram H, Meyer-Marcotty M, Hartmann H, . Variable disease progression after successful stem cell transplantation: prospective follow-up investigations in eight patients with Hurler syndrome. Pediatr Transplant. 2011;15:861–869.
   PubMedGoogle Scholar
• Lange MC, Teive HA, Troiano AR, Bitencourt M, Funke VA, Setúbal DC, . Bone marrow transplantation in patients with storage diseases: a developing country experience. Arq Neuropsiquiatr. 2006;64:1–4.
   Google Scholar
• Sifuentes M, Doroshow R, Hoft R, Mason G, Walot I, Diament M, . A follow-up study of MPS I patients treated with laronidase enzyme replacement therapy for 6 years. Mol Genet Metab. 2007;90:171–80.
   PubMed Web of Science ®Google Scholar
• Souza M, Krug C, Picon P, Schwartz I. High cost drugs for rare diseases in Brazil: the case of lysosomal storage disorders. Ciência Saúde Coletiva (Impresso). 2010;15:3443–554.
   Google Scholar
• Ponder KP, Haskins ME. Gene therapy for mucopolysaccharidosis. Expert Opin Biol Ther. 2007;7:1333–45.
   PubMed Web of Science ®Google Scholar
• Matte U, Lagranha VL, de Carvalho TG, Mayer FQ, Giugliani R. Cell microencapsulation: a potential tool for the treatment of neuronopathic lysosomal storage diseases. J Inherit Metab Dis. 2011;34:983–90.
   PubMed Web of Science ®Google Scholar
• Mayer FQ, Baldo G, de Carvalho TG, Lagranha VL, Giugliani R, Matte U. Effects of cryopreservation and hypothermic storage on cell viability and enzyme activity in recombinant encapsulated cells overexpressing alpha-l-iduronidase. Artif Organs. 2010;34:434–9.
   Google Scholar
• Baldo G, Mayer FQ, Burin M, Carrillo-Farga J, Matte U, Giugliani R. Recombinant encapsulated cells overexpressing alpha-l-iduronidase correct enzyme deficiency in human MPS I cells. Cell Tiss Org. 2012;195:323–9.
   PubMed Web of Science ®Google Scholar
• Ohmi K, Greenberg DS, Rajavel KS, Ryazantsev S, Li HH, Neufeld EF. Activated microglia in cortex of mouse models of mucopolysaccharidoses I and IIIB. Proc Natl Acad Sci USA. 2003;100:1902–7.
   PubMed Web of Science ®Google Scholar
• Bressel T, Paz AH, Baldo G, Cirne-Lima EO, Matte U, Pereira MLS. An effective device for generating alginate microcapsules. Genet Mol Biol 2008;31:136–40.
   Google Scholar
• Lagranha VL, Baldo G, de Carvalho TG, Burin M, Saraiva-Pereira ML, Matte U, Giugliani R. In vitro correction of ARSA deFB01ciency in human skin fibroblasts from metachromatic leukodystrophy patients after treatment with microencapsulated recombinant cells. Metab Brain Dis. 2008;23:469–84.
   PubMed Web of Science ®Google Scholar
• Tavares AM, da Rosa Araújo AS, Baldo G, Matte U, Khaper N, Belló-Klein A, . Bone marrow derived cells decrease inflammation but not oxidative stress in an experimental model of acute myocardial infarction. Life Sci. 2010;87:699–706.
   PubMed Web of Science ®Google Scholar
• Hopwood JJ, Muller V, Smithson A, Baggett N. A fluorometric assay using 4-methylumbelliferyl alpha-l-iduronide for the estimation of alpha-l-iduronidase activity and the detection of Hurler and Scheie syndromes. Clin Chim Acta. 1979; 92:257–65.
   PubMedGoogle Scholar
• Wang D, Shukla C, Liu X, Schoeb TR, Clarke LA, Bedwell DM, Keeling KM. Characterization of an MPS I-H knock-in mouse that carries a nonsense mutation analogous to the human IDUA-W402X mutation. Mol Genet Metab. 2010;99:62–71.
   Google Scholar
• Friso A, Tomanin R, Alba S, Gasparotto N, Puicher EP, Fusco M, . Reduction of GAG storage in MPS II mouse model following implantation of encapsulated recombinant myoblasts. J Gene Med. 2005;7:1482–91.
   PubMed Web of Science ®Google Scholar
• Piller Puicher E, Tomanin R, Salvalaio M, Friso A, Hortelano G, Marin O, Scarpa M. Encapsulated engineered myoblasts can cure Hurler syndrome: preclinical experiments in the mouse model. Gene Ther, in press.
   Google Scholar
• Liu XY, Nothias JM, Scavone A, Garfinkel M, Millis JM. Biocompatibility investigation of polyethylene glycol and alginate-poly-l-lysine for islet encapsulation. Am Soc Art Intern Org J. 2010;56:241–5.
   Google Scholar
• Di Domenico C, Villani GR, Di Napoli D, Reyero EG, Lombardo A, Naldini L, Di Natale P. Gene therapy for a mucopolysaccharidosis type I murine model with lentiviral-IDUA vector. Hum Gene Ther. 2005;16:81–90.
   PubMed Web of Science ®Google Scholar
• Wraith JE, Beck M, Lane R, Ploeg A, Shapiro E, Xue Y, . Enzyme replacement therapy in patients who have mucopolysaccharidosis I and are younger than 5 years: results of a multinational study of recombinant humanα-l-iduronidase (Laronidase). Pediatrics. 2007;120:e37–46.
   PubMed Web of Science ®Google Scholar